| A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications GW Wright, JD Phelan, ZA Coulibaly, S Roulland, RM Young, JQ Wang, ... Cancer cell 37 (4), 551-568. e14, 2020 | 818 | 2020 |
| Conserved pan-cancer microenvironment subtypes predict response to immunotherapy A Bagaev, N Kotlov, K Nomie, V Svekolkin, A Gafurov, O Isaeva, N Osokin, ... Cancer cell 39 (6), 845-865. e7, 2021 | 660 | 2021 |
| Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures N Kotlov, A Bagaev, MV Revuelta, JM Phillip, MT Cacciapuoti, ... Cancer discovery 11 (6), 1468-1489, 2021 | 152 | 2021 |
| Immune profiles in primary squamous cell carcinoma of the head and neck V Saloura, E Izumchenko, Z Zuo, R Bao, M Korzinkin, I Ozerov, ... Oral Oncology 96, 77-88, 2019 | 69 | 2019 |
| Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes A Zaitsev, M Chelushkin, D Dyikanov, I Cheremushkin, B Shpak, K Nomie, ... Cancer Cell 40 (8), 879-894. e16, 2022 | 63 | 2022 |
| Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL J Ruan, A Moskowitz, N Mehta-Shah, L Sokol, Z Chen, N Kotlov, G Nos, ... Blood, The Journal of the American Society of Hematology 141 (18), 2194-2205, 2023 | 56* | 2023 |
| Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression G Han, Q Deng, ML Marques-Piubelli, E Dai, M Dang, MCJ Ma, X Li, ... Blood cancer discovery 3 (5), 428-443, 2022 | 45 | 2022 |
| Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations F Li, L Deng, KR Jackson, AH Talukder, AS Katailiha, SD Bradley, Q Zou, ... Journal for immunotherapy of cancer 9 (7), 2021 | 41 | 2021 |
| Tadalafil enhances immune signatures in response to neoadjuvant nivolumab in resectable head and neck squamous cell carcinoma AJ Luginbuhl, JM Johnson, LA Harshyne, AJ Linnenbach, SK Shukla, ... Clinical Cancer Research 28 (5), 915-927, 2022 | 35 | 2022 |
| Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma R Razzaghi, S Agarwal, N Kotlov, O Plotnikova, K Nomie, DW Huang, ... Journal of Experimental Medicine 218 (3), e20201173, 2020 | 27 | 2020 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov US Patent 10,311,967, 2019 | 23 | 2019 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov, O Isaeva US Patent 11,367,509, 2022 | 22 | 2022 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov, O Isaeva US Patent 11,322,226, 2022 | 21 | 2022 |
| Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas MN Calvo-Vidal, N Zamponi, J Krumsiek, MA Stockslager, MV Revuelta, ... Cancer research 81 (20), 5202-5216, 2021 | 21 | 2021 |
| A new species of Cyanea jellyfish sympatric to C. capillata in the White Sea GD Kolbasova, AO Zalevsky, AR Gafurov, PO Gusev, MA Ezhova, ... Polar Biology 38, 1439-1451, 2015 | 21 | 2015 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov, O Isaeva US Patent 11,430,545, 2022 | 19 | 2022 |
| Single-cell spatial proteomic revelations on the multiparametric MRI heterogeneity of clinically significant prostate cancer RK Pachynski, EH Kim, N Miheecheva, N Kotlov, A Ramachandran, ... Clinical Cancer Research 27 (12), 3478-3490, 2021 | 19 | 2021 |
| Systems and methods for generating, visualizing and classifying molecular functional profiles A Bagaev, F Frenkel, N Kotlov, R Ataullakhanov US Patent 10,650,911, 2020 | 19 | 2020 |
| B cell-enriched tumor microenvironments O Kudryashova, M Shah, N Kotlov, D Melikhova, M Gusakova, ... US Patent App. 17/690,817, 2022 | 18 | 2022 |
| Doublecortin-like kinase 1 (DCLK1) is a novel NOTCH pathway signaling regulator in head and neck squamous cell carcinoma EC Broner, JA Trujillo, M Korzinkin, T Subbannayya, N Agrawal, ... Frontiers in Oncology 11, 677051, 2021 | 17 | 2021 |
